Pacific Edge Ltd. | Cash Flow

Fiscal year is April-March. All values NZD Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
9,951.10
12,475.10
15,676.40
22,586.00
19,644.00
17,918
Depreciation, Depletion & Amortization
384.30
458.80
506.20
540.00
504.00
391
Other Funds
571.30
969.50
1,105.90
3,317.00
1,159.00
804
Funds from Operations
8,995.50
11,046.80
14,064.30
18,729.00
17,981.00
16,723
Changes in Working Capital
528.20
1,492.00
2,888.10
892.00
119.00
784
Net Operating Cash Flow
9,523.60
12,538.80
16,952.40
17,837.00
18,100.00
17,507
Capital Expenditures
497.40
426.50
324.60
479.00
335.00
Purchase/Sale of Investments
11,304.80
-
-
12,000.00
3,000.00
Net Investing Cash Flow
11,802.20
10,073.50
15,324.60
11,521.00
3,335.00
Issuance/Reduction of Debt, Net
-
-
-
-
59.00
Net Financing Cash Flow
19,769.90
-
33,400.20
8,659.00
20,057.00
Net Change in Cash
1,537.40
2,125.00
1,341.70
2,404.00
1,322.00
Free Cash Flow
9,840.50
12,766.40
17,116.40
18,046.00
18,295.00
Other Sources
-
10,500.00
14,000.00
-
-
Change in Capital Stock
19,769.90
-
33,400.20
8,659.00
20,116.00
Exchange Rate Effect
18.50
340.30
218.40
61.00
56.00
Other Uses
-
-
29,000.00
-
-

About Pacific Edge

View Profile
Address
Centre for Innovation
Dunedin OT 9016
New Zealand
Employees -
Website http://www.pacificedgedx.com
Updated 07/08/2019
Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. It operates in the Commercial and Research segments. The Commercial segment involves the sales, marketing, laboratory, and support to run the commercial businesses worldwide.